The global burden of disease study: implications for neurology.

PubWeight™: 2.44‹?› | Rank: Top 2%

🔗 View Article (PMID 10714674)

Published in Arch Neurol on March 01, 2000

Authors

M Menken1, T L Munsat, J F Toole

Author Affiliations

1: World Federation of Neurology, Research Group on Medical Education, London, England. mmenken712@aol.com

Articles citing this

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia (2010) 2.17

Demystifying neurology. BMJ (2002) 2.00

Molecular genetics of migraine. Hum Genet (2009) 1.91

Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia (2011) 1.79

Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77

Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One (2012) 1.76

Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue. BMC Med Educ (2010) 1.58

Cognitive-behavioral group treatment for disabling headache. Pain Med (2004) 1.54

Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med (2014) 1.14

Frequency and clinical patterns of stroke in Iran - Systematic and critical review. BMC Neurol (2010) 1.13

Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol (2014) 1.00

Headache: a 'suitable case' for behavioural treatment in primary care? Br J Gen Pract (2007) 0.95

Building sustainable neuroscience capacity in Africa: the role of non-profit organisations. Metab Brain Dis (2015) 0.95

Migraine headache is present in the aura phase: a prospective study. Neurology (2012) 0.91

Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI). BMC Neurol (2010) 0.90

The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura. J Neurol (2006) 0.90

The ineffective role of cathodal tDCS in enhancing the functional motor outcomes in early phase of stroke rehabilitation: an experimental trial. Biomed Res Int (2014) 0.87

Treating neurodegenerative diseases. BMJ (2002) 0.86

Migraine is a neuronal disease. J Neural Transm (Vienna) (2010) 0.86

Recent advances in the diagnosis and management of migraine. BMJ (2006) 0.83

Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation. Iran Red Crescent Med J (2014) 0.82

Exercise intervention to prevent falls and enhance mobility in community dwellers after stroke: a protocol for a randomised controlled trial. BMC Neurol (2009) 0.82

The validation of ID Migraine screener in neurology outpatient clinics in Turkey. J Headache Pain (2007) 0.82

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine. Neuropsychiatr Dis Treat (2012) 0.80

Activation of the nuclear factor E2-related factor 2 pathway by novel natural products halomadurones A-D and a synthetic analogue. Mar Drugs (2013) 0.80

Efficacy of chuanxiong ding tong herbal formula granule in the treatment and prophylactic of migraine patients: a randomized, double-blind, multicenter, placebo-controlled trial. Evid Based Complement Alternat Med (2012) 0.80

The migrainous brain: what you see is not all you get? PLoS Med (2006) 0.80

National survey of UK medical students on the perception of neurology. BMC Med Educ (2014) 0.80

Interest in neurology during medical clerkship in three Nigerian medical schools. BMC Med Educ (2010) 0.80

The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective. Ther Adv Neurol Disord (2015) 0.79

Occipital nerve stimulation in primary headache syndromes. Ther Adv Neurol Disord (2012) 0.78

Melatonin Counteracts at a Transcriptional Level the Inflammatory and Apoptotic Response Secondary to Ischemic Brain Injury Induced by Middle Cerebral Artery Blockade in Aging Rats. Biores Open Access (2015) 0.78

Neurophobia among medical students and non-specialist doctors in Sri Lanka. BMC Med Educ (2013) 0.78

The Effectiveness of Mindfulness-Based Stress Reduction on Perceived Pain Intensity and Quality of Life in Patients With Chronic Headache. Glob J Health Sci (2015) 0.77

Predictors of adherence to a structured exercise program and physical activity participation in community dwellers after stroke. Stroke Res Treat (2011) 0.77

Investigation of chemokine receptor CCR2V64Il gene polymorphism and migraine without aura in the Iranian population. ScientificWorldJournal (2013) 0.77

Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol (2003) 0.77

Association between carotid area calcifications and periodontal risk: a cross sectional study of panoramic radiographic findings. BMC Cardiovasc Disord (2011) 0.76

Evaluating the prophylaxis and long-term effectiveness of acupuncture for migraine without aura: study protocol for a randomized controlled trial. Trials (2013) 0.76

Curing neurophobia in medical schools: evidence-based strategies. Med Educ Online (2016) 0.76

Microphysiological Human Brain and Neural Systems-on-a-Chip: Potential Alternatives to Small Animal Models and Emerging Platforms for Drug Discovery and Personalized Medicine. Stem Cell Rev (2017) 0.75

Association between Ala379Val polymorphism of lipoprotein-associated phospholipase A2 and migraine without aura in Iranian population. Iran J Neurol (2016) 0.75

Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective. Adv Pharm Bull (2016) 0.75

Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases. Int J Mol Sci (2015) 0.75

OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study. J Headache Pain (2017) 0.75

Headache. Neurotherapeutics (2010) 0.75

Home Exercise Programs for Adults With Neurological Injuries: A Survey. Am J Occup Ther (2016) 0.75

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study. Int J Gen Med (2016) 0.75

Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria. Ethiop J Health Sci (2016) 0.75

The rights of persons with disability bill, 2014: Implications for neurological disability. Ann Indian Acad Neurol (2016) 0.75

Articles by these authors

(truncated to the top 100)

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11

Medical compared with surgical treatment of asymptomatic carotid artery stenosis. Ann Intern Med (1995) 2.72

Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke (1996) 2.51

Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study. Stroke (1991) 2.42

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16

Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation (1990) 1.99

An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study. Stroke (1996) 1.86

Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology (1999) 1.83

Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS Investigators. Stroke (2000) 1.73

Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke (1998) 1.67

Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65

Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy. Hum Mol Genet (1996) 1.61

Transient global amnesia. Ann Neurol (1980) 1.61

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology (2006) 1.57

Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol (1999) 1.48

Quality-based medicine. Arch Neurol (1997) 1.47

Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study. Stroke (1999) 1.46

Presidential disability and the twenty-fifth amendment. JAMA (1994) 1.42

Transient ischemic attacks due to atherosclerosis. A prospective study of 160 patients. Arch Neurol (1975) 1.40

Correlation of carotid bruits and carotid atherosclerosis detected by B-mode real-time ultrasonography. Stroke (1989) 1.39

Inflammatory myopathy with facioscapulohumeral distribution. Neurology (1972) 1.36

Relationship of periodontal disease and edentulism to stroke/TIA. J Dent Res (2003) 1.32

Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology (1999) 1.31

Refinement of the spinal muscular atrophy locus to the interval between D5S435 and MAP1B. Genomics (1993) 1.28

Neurogenic muscular atrophy of infancy with prolonged survival. The variable course of Werdnig-Hoffmann Disease. Brain (1969) 1.24

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research. J Neurol Sci (1999) 1.22

Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology (2001) 1.21

The transient global amnesia-migraine connection. Arch Neurol (1984) 1.21

The Schwartz-Jampel syndrome. Its clinical, physiological and histological expressions. J Neurol Sci (1974) 1.20

Skeletal muscle. Basic and clinical aspects and illustrative new diseases. Ann Intern Med (1967) 1.20

The effect of radiation on carotid arteries. A review article. Arch Neurol (1989) 1.20

Therapy of myotonia. A double-blind evaluation of diphenylhydantoin, procainamide, and placebo. Neurology (1967) 1.17

Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology (1986) 1.15

Effects of change of head, limb and body position on cephalic circulation. N Engl J Med (1968) 1.14

Kinks, coils, and carotids: a review. Stroke (1976) 1.14

Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis (2005) 1.13

Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb (1991) 1.12

Measurement variability of carotid atherosclerosis: real-time (B-mode) ultrasonography and angiography. Stroke (1988) 1.12

Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy. Arch Dis Child (1974) 1.10

Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. The ARIC Study, 1987-1989. Am J Epidemiol (1996) 1.10

Precapillary arteriovenous anastomoses. "Thoroughfare channels" in the brain. Arch Neurol (1967) 1.08

Poliomyelitis--new problems with an old disease. N Engl J Med (1991) 1.06

New evidence for excessive accumulation of Z-band material in nemaline myopathy. Proc Natl Acad Sci U S A (1965) 1.06

Familial myoadenylate deaminase deficiency and exertional myalgia. Neurology (1982) 1.06

Factors influencing the survival of 451 transient ischemic attack patients. Stroke (1987) 1.05

A neuromuscular syndrome of scapuloperoneal distribution. Bull Los Angeles Neurol Soc (1970) 1.04

Serum enzyme alterations in neuromuscular disorders. JAMA (1973) 1.04

Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol (1982) 1.03

Surgical results: a justification of the surgeon selection process for the ACAS trial. The ACAS Investigators. J Vasc Surg (1996) 1.03

Sickle-cell trait: benign or malignant? Ann Intern Med (1972) 1.02

Carotid and vertebrobasilar transient ischemic attacks: clinical and angiographic correlation. Neurology (1979) 1.02

Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology (1986) 1.01

Linkage analysis in familial amyotrophic lateral sclerosis. Neurology (1989) 1.00

Validation of the ACAS TIA/stroke algorithm. Neurology (1997) 1.00

Effect of increased maxillo-mandibular relationship on isometric strength in TMD patients with loss of vertical dimension of occlusion. Cranio (1997) 0.99

Declining morbidity and mortality of carotid endarterectomy. The Wake Forest University Medical Center experience. Stroke (1987) 0.99

Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. III. Factors influencing survival after stroke: proportional hazards analysis of 4219 patients. Stroke (1986) 0.99

Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Neurology (1996) 0.99

Recurrent carotid stenosis : results of the asymptomatic carotid atherosclerosis study. Stroke (1998) 0.99

Risk factors for extracranial carotid artery atherosclerosis. Stroke (1988) 0.98

Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis. Asymptomatic Carotid Atherosclerosis Study investigators. Neurology (2000) 0.97

Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke (1984) 0.97

Multicenter validation study of real-time (B-mode) ultrasound, arteriography, and pathologic examination. J Vasc Surg (1987) 0.97

Centronuclear ("myotubular") myopathy. Arch Neurol (1969) 0.97

Fine-mapping of the spinal muscular atrophy locus to a region flanked by MAP1B and D5S6. Genomics (1992) 0.97

Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res (2000) 0.97

Transient ischemic attacks: a prospective study of 225 patients. Neurology (1978) 0.96

Animal models of alcoholic neuropathy: morphologic, electrophysiologic, and biochemical findings. Muscle Nerve (1980) 0.96

Myopathy with atypical mitochondria in type I skeletal muscle fibers. A histochemical and ultrastructural study. J Neuropathol Exp Neurol (1967) 0.96

Factors influencing return to work following cerebral infarction. JAMA (1985) 0.96

Clinical and computerized tomographic study of hypertensive intracerebral hemorrhage. Arch Neurol (1978) 0.95

Cerebral infarction in patients with transient ischemic attacks. J Neurol (1989) 0.95

Headache and transient ischemic attacks. Stroke (1974) 0.95

Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis. Neurology (1996) 0.95

Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk. Neurology (2011) 0.94

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology (1988) 0.94

Early rehabilitative care in community hospitals: effect on quality of survivorship following a stroke. Stroke (1974) 0.94

Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack. Stroke (1991) 0.94

The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Neurology (1993) 0.93

Transient global amnesia due to glioma in the dominant hemisphere. Neurology (1980) 0.93

Assessment of nonallelic genetic heterogeneity of chronic (type II and III) spinal muscular atrophy. Hum Hered (1994) 0.93

Tubular aggregates in subclinical alcoholic myopathy. Neurology (1975) 0.92

The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology (2000) 0.92

Dominant inheritance of McArdle syndrome. Arch Neurol (1976) 0.92

Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology (2000) 0.92

Bilateral simultaneous sphygmomanometry. A new diagnostic test for subclavian steal syndrome. Circulation (1966) 0.91

Cephalic fibromuscular dysplasia in 32 patients: clinical findings and radiologic features. Arch Neurol (1981) 0.91

Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann Neurol (1998) 0.89

Temporal arteritis associated with normal sedimentation rate. JAMA (1982) 0.88

A comparison of three measures of disease progression in ALS. J Neurol Sci (1996) 0.88

A standardized forearm ischemic exercise test. Neurology (1970) 0.88

Effect of ethanol on lactic acid production by exercised normal muscle. Muscle Nerve (1979) 0.88

Temporal profile resembling TIA in the setting of cerebral infarction. Stroke (1984) 0.87

Nemaline myopathy. A histopathologic and histochemical study. Am J Clin Pathol (1967) 0.87

Conjugal motor neuron disease. Neurology (1982) 0.87

New myopathy with mitochondrial enzyme hyperactivity. Histochemical demonstration. JAMA (1967) 0.87

Cranial computerized tomography in carotid artery transient ischemic attacks. Eur Neurol (1982) 0.87

Use of computerized questionnaire in the etiologic diagnosis of headache. Headache (1974) 0.87

Attracting young people into careers in the health professions. J Med Educ (1970) 0.86